These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34872740)

  • 1. Real-World Anticoagulant Use and Incidence of Venous Thromboembolism and Major Bleeding in Children.
    Hardin J; Michelson AD; McCrindle BW; Pina LM; Peluso C; Simpkins P; Truong H; Knoll C; Yuan Z
    Clin Ther; 2021 Dec; 43(12):2074-2087. PubMed ID: 34872740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer-associated venous thromboembolism.
    Zakai NA; Walker RF; MacLehose RF; Adam TJ; Alonso A; Lutsey PL
    J Thromb Haemost; 2018 Dec; 16(12):2403-2412. PubMed ID: 30240508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism.
    Fang MC; Reynolds K; Fan D; Prasad PA; Sung SH; Portugal C; Garcia E; Go AS
    JAMA Netw Open; 2023 Aug; 6(8):e2328033. PubMed ID: 37581888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis.
    Dawwas GK; Dietrich E; Smith SM; Davis K; Park H
    Clin Ther; 2020 Sep; 42(9):e161-e176. PubMed ID: 32768247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era.
    Kaneda K; Yamashita Y; Morimoto T; Chatani R; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Takada T; Otsui K; Sakamoto J; Ogihara Y; Inoue T; Usami S; Chen PM; Togi K; Koitabashi N; Hiramori S; Doi K; Mabuchi H; Tsuyuki Y; Murata K; Takabayashi K; Nakai H; Sueta D; Shioyama W; Dohke T; Nishikawa R; Ono K; Kimura T
    J Am Heart Assoc; 2024 Aug; 13(15):e034412. PubMed ID: 39082425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct Oral Anticoagulants: Probability of Recurrent Venous Thromboembolism and Bleeding Risk in an Obese Population.
    Pilkerton CS; Adelman M; Crocetti E; Xiang J; Strick V; Ponte CD; Peckens S; Jackson BP; Whipp K; Ashcraft AM
    Ann Pharmacother; 2024 Aug; 58(8):781-789. PubMed ID: 37994550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of major bleeding in adult patients with urogenital and gynecological cancer being treated with direct oral anticoagulants (DOACs): a systematic review.
    Al-Tourah L; Mithoowani S; Lim W; Ikesaka R
    J Thromb Thrombolysis; 2024 Apr; 57(4):630-637. PubMed ID: 38429468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
    Gómez-Outes A; Lecumberri R; Suárez-Gea ML; Terleira-Fernández AI; Monreal M; Vargas-Castrillón E
    J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism.
    Patel A; Williams H; Baer MR; Zimrin AB; Law JY
    Acta Haematol; 2019; 142(4):233-238. PubMed ID: 31108496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE.
    Bounameaux H; Haas S; Farjat AE; Ageno W; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Schellong S; Mantovani LG; Prandoni P; Kakkar AK
    Thromb Res; 2020 Jul; 191():103-112. PubMed ID: 32422442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the Risk Factors Associated with Minor Bleeding in Patients with Venous Thromboembolism during Treatment with Direct Oral Anticoagulants].
    Sunaga T; Shimizu T; Nakamura S; Takahashi N; Higashino M; Matsui M; Hozumi T; Ebato M; Suzuki H; Kogo M; Watanabe T; Sasaki T
    Yakugaku Zasshi; 2019; 139(3):461-467. PubMed ID: 30828024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism.
    Kang HR; Dietrich EA; Huang PL; Lo-Ciganic WH; DeRemer CE; Park H
    Clin Transl Sci; 2023 Jun; 16(6):946-954. PubMed ID: 36891985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2.
    Ogihara Y; Yamashita Y; Morimoto T; Chatani R; Kaneda K; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Takada T; Otsui K; Sakamoto J; Inoue T; Usami S; Chen PM; Togi K; Koitabashi N; Hiramori S; Doi K; Mabuchi H; Tsuyuki Y; Murata K; Takabayashi K; Nakai H; Sueta D; Shioyama W; Dohke T; Sato T; Nishikawa R; Kimura T; Dohi K;
    Thromb Res; 2024 Apr; 236():191-200. PubMed ID: 38461613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
    Rollins BM; Silva MA; Donovan JL; Kanaan AO
    Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct Oral Anticoagulant Use in Chronic Kidney Disease and Dialysis Patients With Venous Thromboembolism: A Systematic Review of Thrombosis and Bleeding Outcomes.
    Cheung CYS; Parikh J; Farrell A; Lefebvre M; Summa-Sorgini C; Battistella M
    Ann Pharmacother; 2021 Jun; 55(6):711-722. PubMed ID: 33073581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight.
    Perales IJ; San Agustin K; DeAngelo J; Campbell AM
    Ann Pharmacother; 2020 Apr; 54(4):344-350. PubMed ID: 31672028
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct oral anticoagulants and bleeding risk (in comparison to vitamin K antagonists and heparins), and the treatment of bleeding.
    Palareti G
    Semin Hematol; 2014 Apr; 51(2):102-11. PubMed ID: 24861794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of venous thromboembolism in patients with inherited thrombophilia treated with direct oral anticoagulants: insights from the RIETE registry.
    Cohen O; Kenet G; Levy-Mendelovich S; Tzoran I; Brenner B; De Ancos C; López-Miguel P; Varona JF; Catella J; Monreal M;
    J Thromb Thrombolysis; 2024 Apr; 57(4):710-720. PubMed ID: 38491267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants.
    Kaneda K; Yamashita Y; Morimoto T; Chatani R; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Takada T; Otsui K; Kimura T;
    Eur J Intern Med; 2023 Dec; 118():59-72. PubMed ID: 37574348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.